secwatch.observer — SEC 8-K summary
======================================

Issuer:     Surface Oncology, Inc. (—)
CIK:        0001718108
Form:       8-K
Filed at:   2023-01-12T23:59:59+00:00
Accession:  0001193125-23-007282
Event type: regulatory
Sentiment:  negative
Materiality: 0.75
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Surface Oncology receives Nasdaq deficiency notice for bid price below $1.00
----------------------------------------------------------------------------

- Received Nasdaq deficiency letter on Jan 6, 2023, for failing minimum $1.00 bid price for 30 consecutive days.
- Has 180 calendar days, until July 5, 2023, to regain compliance with Rule 5550(a)(2).
- Can regain compliance if bid price closes at $1.00 or more for 10 consecutive business days before deadline.
- If not compliant by July 5, may seek a second 180-day period or face potential delisting.
- Company is monitoring price and considering options, including a possible reverse stock split.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1718108/000119312523007282/0001193125-23-007282-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1718108/000119312523007282/d396065d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-007282

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer